BAYER-MONSANTO FAILS (AT FIRST ATTEMPT) TO BLOCK MEXICO’S PHASEOUT OF GLYPHOSATE AND BAN ON GMO CORN | WHAT REALLY HAPPENED X-Frame-Options: DENY X-Frame-Options: SAMEORIGIN

BAYER-MONSANTO FAILS (AT FIRST ATTEMPT) TO BLOCK MEXICO’S PHASEOUT OF GLYPHOSATE AND BAN ON GMO CORN

Mexico has already gone mano a mano with Monsanto before, and it came out on top. But this time it’s on direct collision course with the U.S. government.

Life used to be a whole lot easier for German pharmaceutical and crop science company Bayer. But that was before it bought the scandal-tarnished US GMO giant Monsanto for $66 billion. And it has paid a heck of a price. Now worth just $53 billion — $13 billion less than what it paid for Monsanto in 2018 — Bayer has faced tens of thousands of lawsuits claiming that Monsanto’s Roundup weed killer caused non-Hodgkin’s lymphoma. The German company has agreed to pay as much as $11.5 billion to resolve existing US litigation.

It has also proposed to pay a further $2 billion into a fund that would cover people who’ve been using Roundup but haven’t yet developed non-Hodgkin lymphoma, or just haven’t filed a lawsuit yet. But it also continues to reject claims that Roundup causes cancer even as new lawsuits pile up against it. And it wants to assemble its own panel of expert scientists — as opposed to an independent jury — to rule on the viability of those future claims, which is hardly in the interest of those filing the claims.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA